All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

An urgent urology consultation is requested for a 55-year-old female admitted to the intensive care unit with worsening distributive shock. She initially sought care at an outpatient clinic three days prior for left-sided back pain and dysuria, where she was prescribed oral nitrofurantoin. Her clinical status has deteriorated significantly over the past 12 hours.

Current vital signs reveal a temperature of $39.6^\circ\text{C}$ ( $103.3^\circ\text{F}$ ), heart rate of $128\text{/min}$ , blood pressure of $80/48\text{ mm Hg}$ despite a $3\text{-L}$ intravenous crystalloid bolus and initiation of norepinephrine, and respiratory rate of $24\text{/min}$ . Physical examination demonstrates a lethargic, diaphoretic patient with pronounced left costovertebral angle tenderness.

Laboratory analysis reveals:

Test	Result
Leukocyte count	$24,500/\mu\text{L}$ (with $18\%$ bands)
Hemoglobin	$11.2\text{ g/dL}$
Platelet count	$98,000/\mu\text{L}$
Serum creatinine	$2.6\text{ mg/dL}$ (Baseline: $0.8\text{ mg/dL}$ )
Lactic acid	$4.8\text{ mmol/L}$

A non-contrast computed tomography scan of the abdomen and pelvis shows severe left hydroureteronephrosis secondary to an $11\text{-mm}$ radiopaque calculus lodged at the ureteropelvic junction, accompanied by significant perinephric fat stranding. Broad-spectrum intravenous antibiotics are currently being administered.

Which of the following procedural interventions is the most appropriate next step in the management of this patient?

Placement of a percutaneous nephrostomy tube

Extracorporeal shock wave lithotripsy

Retrograde ureteroscopy with stone extraction

Open surgical ureterolithotomy

Bilateral retrograde pyelography

Show answer & explanation

Answer: Placement of a percutaneous nephrostomy tube

Answer

Placement of a percutaneous nephrostomy tube

This patient is presenting with septic shock secondary to an obstructing ureteral calculus. An infected, obstructed urinary tract is a true urologic emergency because the elevated intrapelvic pressure impairs antibiotic penetration and continuously seeds bacteria into the systemic circulation. The most critical step in management, alongside fluid resuscitation and broad-spectrum antibiotics, is immediate decompression of the collecting system to achieve source control. Placement of a percutaneous nephrostomy tube (or a retrograde double-J ureteral stent) provides rapid, minimally invasive drainage of the infected urine. Definitive management of the stone itself must be deferred until the patient is hemodynamically stable and the infection has been adequately treated.

Step-by-Step Solution

Identify the patient's clinical syndrome based on the presentation and vital signs.

The patient is in septic shock (hypotension requiring vasopressors, lactic acidosis, fever, leukocytosis).

Recognizing the severity of the illness dictates the urgency and type of intervention required.

Correlate the physical exam and imaging findings with the clinical syndrome to determine the source of infection.

The CT scan and physical exam confirm an infected, obstructed left kidney (obstructive pyelonephritis/urosepsis) secondary to an 11-mm calculus.

An obstructed and infected kidney behaves as a closed-space abscess that continuously seeds bacteria into the bloodstream.

Select the most appropriate definitive intervention for this specific urologic emergency.

Immediate decompression of the collecting system via a percutaneous nephrostomy tube (or retrograde ureteral stent) is required.

In hemodynamically unstable patients, minimally invasive source control is mandatory, whereas definitive stone removal procedures are contraindicated until the patient stabilizes.

Key Concept

In patients with obstructive pyelonephritis and septic shock, urgent decompression of the urinary tract via percutaneous nephrostomy or ureteral stenting is required for source control; definitive stone removal is deferred until the infection resolves.

Question 4402Question →

An 82-year-old man is evaluated for discharge planning. He was admitted to the hospital one week ago for urosepsis complicated by acute kidney injury. During the first few days of his admission, he required temporary hemodialysis and intensive care monitoring. His clinical status has since improved significantly; his renal function has recovered, dialysis has been discontinued, and he was transitioned to oral antibiotics yesterday. Current vital signs are temperature 37.0°C (98.6°F), blood pressure 130/80 mmHg, pulse 72/min, and respiratory rate 14/min. Prior to admission, he was fully independent and served as the primary caregiver for his 80-year-old wife, who has severe osteoarthritis and is bound to a motorized wheelchair. They live in a ground-floor apartment. Today, physical and occupational therapy evaluations reveal profound generalized weakness. The patient requires maximum physical assistance to transition from sitting to standing and can only take a few steps using a rolling walker. He fatigues quickly, tolerating approximately 60 minutes of physical therapy per day. Which of the following is the most appropriate discharge disposition for this patient?

Discharge home with outpatient physical therapy

Discharge home with home health services

Discharge to a long-term acute care hospital

Discharge to an inpatient rehabilitation facility

Discharge to a skilled nursing facility

Show answer & explanation

Answer: Discharge to a skilled nursing facility

Answer

Discharge to a skilled nursing facility

The correct disposition is a skilled nursing facility (SNF). This patient is medically stable for discharge but has severe, new-onset functional impairments requiring maximum assistance for mobility. Because his wife is wheelchair-bound and cannot physically assist him, returning home is unsafe, even with intermittent home health services. The patient requires residential care that provides assistance with activities of daily living (ADLs) alongside ongoing physical and occupational therapy. While an inpatient rehabilitation facility (IRF) also provides residential therapy, Medicare guidelines require patients in an IRF to be able to tolerate and participate in at least 3 hours of intensive therapy daily. This patient fatigues after 60 minutes, making an SNF—which offers subacute rehabilitation at a lower intensity—the most appropriate setting.

Step-by-Step Solution

Evaluate the patient's medical stability for discharge.

The patient is hemodynamically stable, off dialysis, and taking oral medications.

This confirms he no longer requires acute inpatient medical care or long-term acute care hospital (LTACH) interventions.

Assess the patient's new functional deficits, rehabilitation needs, and endurance level.

He requires maximum assistance for transfers and can only tolerate 60 minutes of physical therapy daily.

This determines the appropriate intensity of post-acute rehabilitation required (IRF vs. SNF).

Analyze the patient's social support and home environment.

Although he lives with his wife, she is wheelchair-bound and incapable of providing the maximum physical assistance he currently requires.

This determines whether returning home, with or without home health services, is a safe option.

Synthesize the clinical and social findings to select the definitive care setting.

The patient cannot return home safely and lacks the endurance for an inpatient rehabilitation facility. Therefore, a skilled nursing facility is the most appropriate choice.

It aligns his need for subacute, lower-intensity rehabilitation and 24-hour custodial care.

Key Concept

Appropriate patient disposition requires synthesizing medical stability, functional status, physical endurance (e.g., the 3-hour daily therapy rule for IRFs), and available home social support.

Question 4403Question →

A 29-year-old female patient is evaluated in the surgical intensive care unit on postoperative day two following an uncomplicated open cholecystectomy. Over the past four hours, she has become profoundly delirious and agitated. Her husband notes she has a history of "mild hyperthyroidism" for which she had been taking medication intermittently, but she completely discontinued all medical therapy one month ago.

Vital signs demonstrate a temperature of $39.8^\circ\text{C}$ ( $103.6^\circ\text{F}$ ), pulse of $158/\text{min}$ , blood pressure of $152/68\text{ mmHg}$ , and respirations of $28/\text{min}$ .

Physical examination reveals an actively hallucinating and diaphoretic patient. Ophthalmic examination shows bilateral proptosis and lid retraction. The thyroid gland is diffusely enlarged, firm, and a continuous bruit is audible over the lateral lobes. Cardiovascular examination reveals a regular, rapid rhythm with a hyperdynamic precordium. A fine tremor is present in the upper extremities. Laboratory studies reveal a TSH of $<0.01\text{ }\mu\text{U/mL}$ and free T4 of $5.8\text{ ng/dL}$ .

Arrange the following pharmacologic interventions in the strictly correct chronological sequence to maximize therapeutic efficacy and prevent an acute exacerbation of this patient's underlying condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of administration is intravenous propranolol, followed by oral propylthiouracil, then saturated solution of potassium iodide, and finally oral cholestyramine.

The precise chronological management of thyroid storm targets the thyroid hormone pathway at multiple levels. Intravenous propranolol is given first to provide rapid control of the severe hyperadrenergic state and prevent cardiovascular collapse. Next, a thionamide such as propylthiouracil is administered to halt the synthesis of new thyroid hormone via inhibition of thyroid peroxidase. Crucially, at least one hour after the thionamide is given, an iodine solution (such as saturated solution of potassium iodide) is administered to halt the release of preformed hormone via the Wolff-Chaikoff effect. Finally, adjuvant agents like cholestyramine can be administered to interrupt the enterohepatic recycling of circulating thyroid hormone, further accelerating clinical recovery.

Step-by-Step Solution

Diagnose the underlying clinical emergency based on the presentation.

The patient is experiencing a postoperatively triggered thyroid storm (Burch-Wartofsky point scale score > 45, evidenced by extreme fever, tachycardia, agitation, and gastrointestinal/hepatic dysfunction).

Identifying thyroid storm dictates the need for a highly specific, multi-agent pharmacologic blockade sequence.

Identify the primary intervention needed to prevent immediate cardiovascular collapse.

Place intravenous propranolol first in the sequence.

Beta-blockers rapidly blunt target-organ responsiveness to the massive adrenergic surge and simultaneously inhibit type 1 deiodinase, reducing peripheral conversion of T4 to T3.

Determine the necessary order of agents acting directly on the thyroid gland.

Place oral propylthiouracil (PTU) second, and potassium iodide third.

PTU must be administered to block new hormone synthesis. Iodine (to block hormone release) MUST be delayed until at least 1 hour after PTU to prevent the iodine from being utilized as a substrate to synthesize even more thyroid hormone.

Identify the role of adjuvant therapy for hormone clearance.

Place oral cholestyramine last in the sequence.

Cholestyramine binds thyroid hormones in the gut to prevent enterohepatic recycling. It is a secondary, supportive measure utilized after the immediate synthesis and release pathways are chemically blockaded.

Key Concept

Pharmacologic management of thyroid storm requires a strict sequence: beta-blockade for symptom control, thionamides to halt synthesis, iodine to halt release (strictly after thionamides), and finally adjuvant agents like bile acid sequestrants or glucocorticoids.

Question 4404Question →

A 74-year-old female patient with a history of severe chronic obstructive pulmonary disease is preparing for transfer to a post-acute rehabilitation facility following a prolonged hospitalization for acute hypoxic respiratory failure. Her clinical status has stabilized, and the hospital team is initiating the discharge process. To ensure a safe transition of care and adhere to established discharge protocols, arrange the following transitional care steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for a safe care transition is: 1) Perform a comprehensive multidisciplinary assessment, 2) Reconcile the inpatient medication list, 3) Conduct a teach-back education session, 4) Generate and transmit the formal discharge summary, and 5) Coordinate primary care follow-up appointments.

Transitional care protocols (such as Project RED or BOOST) emphasize a logical workflow: the patient's needs must first be assessed to dictate the plan. Next, medications must be fully reconciled to prevent errors. Only after the regimen is finalized can effective teach-back education occur. Following education, the complete, finalized summary is transmitted to the receiving clinicians. Finally, outpatient follow-up is scheduled to ensure long-term continuity.

Step-by-Step Solution

Assess post-acute facility requirements

Identifies the specific level of care and therapy needed for the patient.

This establishes the target destination and sets the framework for the entire discharge plan.

Reconcile medications

Creates an accurate, finalized list of medications the patient will take after leaving.

Prevents adverse drug events and serves as the required foundation for patient education and transfer orders.

Conduct patient and family education

Verifies that the patient and caregivers understand the care plan and newly prescribed medications.

Patient comprehension significantly reduces the risk of readmission and medical errors.

Transmit discharge summary and orders

Provides the receiving facility with the comprehensive clinical context and active orders.

Ensures a safe and informed clinical handoff between care teams.

Coordinate follow-up and transitional calls

Secures post-discharge appointments and oversight.

Maintains long-term continuity of care after the immediate handover is completed.

Key Concept

Safe care transitions require a structured, chronological approach prioritizing destination assessment, medication reconciliation, patient education, provider handoff, and outpatient continuity.

Question 4405Question →

A 24-year-old male is transported to the emergency department by ambulance after being found unresponsive in his apartment. Paramedics report finding empty bottles of amitriptyline and alprazolam on his nightstand.

Upon arrival, the patient responds only with incomprehensible sounds to a deep sternal rub. His respirations are shallow and sonorous. Vital signs demonstrate a blood pressure of 82/48 mmHg, heart rate of 138/min, and respiratory rate of 8/min with an oxygen saturation of 88% on room air. The bedside cardiac monitor displays a wide-complex regular rhythm with a QRS duration of 155 ms.

Arrange the following management steps in the most appropriate sequential order to stabilize and evaluate this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of initial management is: 1) Provide advanced airway management with endotracheal intubation, 2) Establish vascular access and initiate volume resuscitation, 3) Administer an intravenous bolus of sodium bicarbonate, 4) Obtain laboratory studies including a toxicology panel.

The patient is in shock and respiratory failure secondary to a suspected tricyclic antidepressant overdose. According to primary life support principles, securing a compromised airway is the most critical priority and must precede all other interventions. After the airway is secured, the next sequential priority is establishing basic circulation with intravenous access and isotonic fluid resuscitation. Once basic circulation is supported, targeted antidotal therapy with sodium bicarbonate is administered to address the widened QRS complex and prevent fatal arrhythmias. Finally, after immediate life threats are stabilized, diagnostic laboratory studies can be safely obtained.

Step-by-Step Solution

Assess the airway and breathing.

The patient is unresponsive with sonorous, shallow respirations and hypoxia, indicating severe airway compromise.

The primary survey always begins with airway assessment to identify immediate life threats.

Provide advanced airway management with endotracheal intubation.

The airway is secured and oxygenation is supported.

Inability to protect the airway is an immediate life threat that supersedes all other interventions.

Assess circulation and establish vascular access for volume resuscitation.

Basic circulation is supported with isotonic fluids for hypotension.

Once the airway is secure, severe hypotension must be rapidly addressed, and vascular access is required for medication delivery.

Administer an intravenous bolus of sodium bicarbonate.

The QRS complex narrows, reducing the risk of ventricular dysrhythmias.

Sodium bicarbonate overcomes sodium channel blockade from the tricyclic antidepressant ingestion.

Obtain laboratory studies including a toxicology panel.

Diagnostic data is gathered to guide ongoing management.

Comprehensive evaluation occurs only after the primary ABC survey and immediate life-saving stabilization are complete.

Key Concept

The ATLS/ACLS prioritization algorithm (Airway, Breathing, Circulation) dictates that securing a compromised airway takes precedence over fluid resuscitation, specific antidotal therapy, and diagnostic testing in the critically ill poisoned patient.

Estimated Time:1m 30s

Question 4406Question →

A 54-year-old man is brought to the emergency department after coughing up approximately 700 mL of bright red blood over the past two hours. He has a history of treated pulmonary tuberculosis with known residual cavitary disease in the right upper lobe. Upon arrival, he continues to expectorate large volumes of blood and appears in moderate respiratory distress. Vital signs are temperature 37.1°C (98.8°F), blood pressure 112/68 mmHg, pulse 118/min, and respiratory rate 28/min. Oxygen saturation is 87% on room air.

Arrange the following management and procedural interventions in the most appropriate chronological sequence for this patient's presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The most appropriate chronological sequence is: 1) Place the patient in the right lateral decubitus position, 2) Perform endotracheal intubation to secure the airway, 3) Perform emergent bronchoscopy, and 4) Proceed with bronchial artery embolization.

In massive hemoptysis, the primary cause of mortality is asphyxiation due to airway flooding, rather than hemorrhagic shock. Therefore, immediate management prioritizes airway protection and gas exchange. The sequence begins with a rapid positional maneuver: placing the suspected bleeding side (the right lung, given the known cavitary disease) in the dependent position. This gravity-dependent 'right side down' position protects the unaffected left lung from blood aspiration. Next, formal airway security is achieved via endotracheal intubation, utilizing a large-bore tube to maintain ventilation and allow equipment passage. With the airway secured, emergent bronchoscopy is the third step to evacuate clots, precisely localize the bleeding, and attempt local hemostasis. Finally, the patient undergoes bronchial artery embolization, which is the definitive procedural intervention to occlude the bleeding vessel.

Step-by-Step Solution

Identify the immediate life threat and protect the unaffected lung.

The patient is placed in the right lateral decubitus position.

Massive hemoptysis typically causes death by asphyxiation, not exsanguination. Placing the bleeding lung (right, given the history of right upper lobe cavitary disease) in the dependent position utilizes gravity to prevent blood from spilling into the healthy left lung.

Secure the airway and ensure adequate ventilation.

Endotracheal intubation is performed.

Airway control is paramount. A large-bore endotracheal tube (minimum size 8.0) is placed to protect against asphyxiation, allow mechanical ventilation, and facilitate subsequent bronchoscopic interventions.

Localize the bleeding source and clear the airways.

Emergent bronchoscopy is performed.

Bronchoscopy allows direct visualization to confirm the bleeding site, removes obstructive blood clots, and can provide initial therapeutic interventions such as cold saline lavage or balloon tamponade.

Achieve definitive hemorrhage control.

Bronchial artery embolization is performed.

Embolization is the preferred definitive, minimally invasive procedure to halt bronchial artery bleeding once the patient is stabilized and the bleeding site is localized.

Key Concept

Management sequence for massive hemoptysis focuses sequentially on positional airway protection, definitive airway security, diagnostic/therapeutic bronchoscopy, and finally definitive endovascular or surgical control.

Question 4407Question →

A 57-year-old woman comes to the clinic reporting severe, generalized muscle aches and profound fatigue that began two days ago. She also notes that her urine has become unusually dark, resembling the color of tea. Five days ago, she was diagnosed with Helicobacter pylori infection and was started on a 14-day eradication regimen consisting of pantoprazole, amoxicillin, and clarithromycin. Her past medical history is significant for hyperlipidemia and hypertension, for which she takes simvastatin and lisinopril daily. Her temperature is 37.1°C (98.8°F), blood pressure is 126/82 mmHg, and pulse is 78/min. Physical examination reveals tenderness to palpation over the bilateral deltoid and quadriceps muscles. Neurologic examination shows 4/5 strength in the proximal upper and lower extremities with normal deep tendon reflexes. A urine dipstick performed in the clinic is positive for 3+ blood, but the microscopic examination reveals 0 to 1 red blood cells per high-power field. Which of the following is the most appropriate next step in the management of this patient?

Discontinue simvastatin and obtain a serum creatine kinase level

Discontinue simvastatin, initiate atorvastatin, and obtain a serum creatine kinase level

Initiate empiric ciprofloxacin for a suspected urinary tract infection

Obtain a comprehensive metabolic panel to check liver enzymes and continue the current medication regimen

Schedule an urgent electromyography to evaluate for toxic myopathy

Show answer & explanation

Answer: Discontinue simvastatin and obtain a serum creatine kinase level

Answer

The most appropriate next step is to discontinue simvastatin and obtain a serum creatine kinase level.

The correct action is to discontinue simvastatin and obtain a serum creatine kinase level. The patient has developed statin-induced rhabdomyolysis triggered by the recent addition of clarithromycin. Simvastatin undergoes extensive first-pass metabolism by the hepatic enzyme CYP3A4. Clarithromycin is a potent CYP3A4 inhibitor. When given together, simvastatin levels rapidly rise to toxic concentrations, causing skeletal muscle breakdown. This breakdown releases myoglobin into the bloodstream, which is filtered by the kidneys and causes the urine to appear dark. Myoglobin triggers a positive "blood" reading on a urine dipstick, but true red blood cells will be absent on microscopic examination. The immediate management involves stopping the offending statin to halt further muscle damage and measuring a serum creatine kinase (CK) level to confirm rhabdomyolysis and guide intravenous hydration therapy.

Step-by-Step Solution

Interpret the clinical and laboratory presentation.

The patient exhibits proximal muscle weakness, myalgias, and tea-colored urine, with a urinalysis showing false-positive blood (positive dipstick, negative microscopy).

This combination is the classic presentation of rhabdomyolysis with myoglobinuria, where myoglobin cross-reacts with the dipstick reagent for hemoglobin.

Identify the underlying etiology by reviewing the medication list.

The patient recently started clarithromycin while taking maintenance simvastatin.

Clarithromycin is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme, which is responsible for metabolizing simvastatin. This leads to toxic systemic accumulation of the statin.

Determine the most appropriate immediate management.

Stop the simvastatin and order a serum creatine kinase (CK) level.

Removing the precipitating medication prevents further muscle necrosis, and a CK level is required to confirm the diagnosis and guide the need for aggressive intravenous fluid resuscitation to protect renal function.

Key Concept

The concomitant use of strong CYP3A4 inhibitors (e.g., macrolides like clarithromycin) and CYP3A4-metabolized statins (e.g., simvastatin, lovastatin, atorvastatin) can precipitate life-threatening rhabdomyolysis, requiring immediate discontinuation of the statin and assessment of serum creatine kinase.

Question 4408Question →

A 71-year-old man visits his primary care physician for an annual health maintenance examination. He feels well and reports no new symptoms. His medical history includes essential hypertension and hyperlipidemia. He is a former smoker with a 30-pack-year history, having quit entirely 12 years ago. Medical records confirm he underwent a screening colonoscopy at age 63, which was normal. An abdominal aortic ultrasound performed at age 67 revealed no aneurysm. His only vaccinations over the past decade have been annual influenza shots and appropriate COVID-19 boosters. He takes lisinopril and atorvastatin. Vital signs today are within normal limits. Which of the following preventive interventions are currently indicated for this patient? (Select all that apply)

Select all that apply

Annual low-dose computed tomography of the chest

Administration of the recombinant zoster vaccine

Repeat screening colonoscopy

Routine prostate-specific antigen testing

Repeat abdominal aortic aneurysm screening ultrasound

Show answer & explanation

Answer: Annual low-dose computed tomography of the chest; Administration of the recombinant zoster vaccine

Answer

The currently indicated interventions are annual low-dose computed tomography of the chest and administration of the recombinant zoster vaccine.

This patient requires annual lung cancer screening with low-dose computed tomography (LDCT) because he meets all current USPSTF criteria: he is between the ages of 50 and 80, has at least a 20 pack-year smoking history, and quit within the past 15 years (he quit 12 years ago). Additionally, the recombinant zoster vaccine (RZV) is recommended as a two-dose series for all adults aged 50 years and older to prevent shingles and postherpetic neuralgia. Since his only recent vaccines are influenza and COVID-19, he is due for the RZV series.

Step-by-Step Solution

Evaluate lung cancer screening eligibility.

Indicated.

The patient is 71 years old, has a >20 pack-year smoking history, and quit <15 years ago, meeting USPSTF criteria for annual LDCT.

Evaluate vaccination needs.

Recombinant zoster vaccine indicated.

The RZV series is universally recommended for adults over age 50, and his immunization history indicates he has not received it.

Evaluate colorectal cancer screening status.

Not indicated today.

His last normal colonoscopy was at age 63; the normal interval is 10 years, meaning his next screening is due at age 73.

Evaluate prostate cancer screening appropriateness.

Not indicated.

The USPSTF recommends against routine PSA screening in men aged 70 and older.

Evaluate AAA screening status.

Not indicated.

He already had his required one-time AAA screening ultrasound at age 67, which was normal.

Key Concept

Application of age- and risk-appropriate preventive screening and immunization guidelines in the ambulatory setting.

Question 4409Question →

A triage nurse calls the physician to immediately evaluate a patient who just arrived with profound muscle weakness. The patient is a 57-year-old male with a history of hypertension, type 2 diabetes mellitus, and end-stage renal disease who reports missing his last two scheduled hemodialysis sessions due to severe regional weather. He complains of a heavy sensation in his limbs and perioral numbness that began earlier today. His blood pressure is 150/88 mmHg, heart rate is 52/min, and respiratory rate is 18/min. Cardiopulmonary auscultation is unremarkable, but neurologic examination reveals symmetric 3/5 weakness in the proximal and distal muscles of all four limbs. An urgent 12-lead electrocardiogram is obtained and displays significantly peaked T waves, flattened P waves, and a widened QRS complex. A venous blood gas analysis indicates a serum potassium concentration of 7.9 mEq/L.

Arrange the following pharmacologic therapies in the correct chronological sequence for the acute management of this life-threatening presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for managing life-threatening hyperkalemia is to first administer intravenous calcium gluconate to stabilize the cardiac membrane, followed by intravenous regular insulin and 50% dextrose to temporarily shift potassium intracellularly, and finally oral sodium polystyrene sulfonate to definitively eliminate potassium from the body.

The exact chronological order leverages the onset of action of each drug to prevent mortality. Calcium gluconate works within 1 to 3 minutes to stabilize the myocardium. Insulin and dextrose work within 15 to 30 minutes to temporarily shift potassium into cells. Sodium polystyrene sulfonate takes 2 to 6 hours to definitively remove potassium from the body.

Step-by-Step Solution

Identify life-threatening hyperkalemia with cardiac toxicity.

The patient's ECG shows peaked T waves and widened QRS complexes, correlating with a severe potassium level of 7.9 mEq/L.

Recognizing electrical instability dictates the immediate need for cardioprotective measures before attempting to lower the potassium level.

Administer a cardioprotective agent.

Intravenous calcium gluconate is placed in the first position.

To rapidly stabilize the myocardial resting membrane potential and prevent imminent lethal arrhythmias.

Initiate temporary potassium-shifting therapy.

Intravenous regular insulin with 50% dextrose is placed in the second position.

To quickly drive extracellular potassium into the cells (onset 15-30 minutes), thereby temporarily lowering the serum potassium concentration while waiting for definitive elimination.

Administer a definitive potassium-eliminating therapy.

Oral sodium polystyrene sulfonate is placed in the third position.

To definitively remove excess potassium from the body via the gastrointestinal tract, noting that this step takes several hours to take effect.

Key Concept

In the acute management of severe hyperkalemia with electrocardiographic changes, therapy must follow a strict physiologic sequence: cardiac membrane stabilization (intravenous calcium), followed by rapid intracellular potassium shifting (intravenous insulin/glucose, beta-agonists), and finally total body potassium elimination (diuretics, gastrointestinal binders, or hemodialysis).

Estimated Time:1m 15s

Question 4410Question →

A 43-year-old previously healthy female is evaluated in the outpatient clinic for a six-month history of progressive fatigue and breathlessness upon exertion. She has no chronic medical conditions, takes no medications, and has never smoked. Vital signs include a heart rate of 92/min, blood pressure of 110/70 mm Hg, and oxygen saturation of 97% on room air. Jugular venous pressure is estimated at 8 cm H2O. Auscultation reveals a prominently accentuated pulmonary component of the second heart sound and a faint holosystolic murmur at the lower left sternal border. Lungs are clear. Arrange the following diagnostic studies in the most appropriate, guideline-recommended stepwise sequence for evaluating this patient's suspected condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The optimal diagnostic sequence is: 1) Transthoracic echocardiography, 2) Pulmonary function testing and nocturnal oximetry, 3) Radionuclide ventilation-perfusion (V/Q) scanning, and finally 4) Right heart catheterization.

The diagnostic workup for pulmonary hypertension follows a strict stepwise approach to minimize risk and progressively rule out the most common causes. Transthoracic echocardiography is the mandatory initial step to establish the probability of pulmonary hypertension and assess left-sided cardiac structures (Group 2). Once echocardiography indicates intermediate or high probability, the next non-invasive step is to rule out intrinsic lung diseases and hypoxia (Group 3) using pulmonary function testing and oximetry. Subsequently, a V/Q scan is required to rule out chronic thromboembolic pulmonary hypertension (Group 4), as V/Q scanning is more sensitive than CT angiography for chronic organized thromboembolic disease. Only after these secondary causes have been evaluated should a patient undergo right heart catheterization. This invasive procedure provides the definitive hemodynamic parameters (mean pulmonary artery pressure greater than 20 mm Hg, pulmonary vascular resistance greater than or equal to 3 Wood units, and pulmonary capillary wedge pressure less than or equal to 15 mm Hg) necessary to diagnose Group 1 pulmonary arterial hypertension and allows for vasoreactivity testing.

Step-by-Step Solution

Identify the patient's clinical presentation.

The patient exhibits classic signs of pulmonary hypertension, including exertional dyspnea, an accentuated P2, and a holosystolic murmur suggestive of tricuspid regurgitation.

Recognizing the clinical syndrome dictates the specific diagnostic algorithm for pulmonary hypertension.

Determine the initial screening modality.

Transthoracic echocardiography is selected.

Echocardiography non-invasively estimates pulmonary artery pressures and rules out left-sided heart disease, the most common cause of pulmonary hypertension overall.

Sequence testing for secondary underlying causes.

Pulmonary function testing followed by V/Q scanning are placed next in the sequence.

Before invasive testing, non-invasive modalities must rule out Group 3 (lung disease/hypoxia) and Group 4 (chronic thromboembolic) etiologies.

Select the final confirmatory test.

Right heart catheterization is placed last.

Invasive hemodynamic confirmation is required to formally diagnose Group 1 pulmonary arterial hypertension and guide targeted vasodilator therapy.

Key Concept

Diagnostic algorithm for pulmonary hypertension: initial echocardiographic screening, evaluation of secondary causes (Groups 2, 3, and 4), and definitive hemodynamic confirmation via right heart catheterization.

Estimated Time:1m 30s

Question 4411Question →

A 47-year-old woman is evaluated on the surgical ward for acute respiratory distress. Four hours ago, she underwent an uncomplicated total thyroidectomy for a large, symptomatic multinodular goiter. The cross-covering physician is called to the bedside because the patient is highly anxious and complaining of severe difficulty breathing. Her temperature is 37.2°C (99.0°F), blood pressure is 158/92 mmHg, heart rate is 116/min, and oxygen saturation is 86% on room air. Physical examination reveals a diaphoretic woman using accessory muscles of respiration. High-pitched inspiratory stridor is audible. There is a tense, rapidly expanding, ecchymotic swelling beneath the surgical incision, which is closed with surgical clips. Which of the following is the most appropriate next step in the management of this patient?

Immediate removal of surgical clips and opening of the deep cervical fascia

Immediate orotracheal intubation using direct laryngoscopy

Emergent transfer to the operating room for surgical exploration

Administration of intravenous dexamethasone and nebulized racemic epinephrine

Computed tomography angiography of the neck

Show answer & explanation

Answer: Immediate removal of surgical clips and opening of the deep cervical fascia

Answer

The most appropriate next step is immediate removal of surgical clips and opening of the deep cervical fascia at the bedside.

The correct answer addresses the immediate mechanical threat to the patient's life. An expanding hematoma following thyroid surgery can cause rapid airway compromise through direct tracheal compression and impairment of venous drainage, leading to massive laryngeal edema. When a patient presents with stridor and hypoxia, there is no time to wait for an operating room or attempt complex intubations through distorted anatomy. The immediate, life-saving step is to evacuate the hematoma at the bedside by removing the surgical clips and opening the deep cervical fascia. Once the tension is relieved, the patient's airway typically improves, allowing for safe transport back to the operating room for definitive exploration and hemostasis.

Step-by-Step Solution

Analyze the patient's presentation

Identify acute respiratory distress, stridor, and hypoxia 4 hours after a total thyroidectomy.

Recognizing the timeline and specific surgical history narrows the differential diagnosis to acute post-operative complications.

Evaluate the physical examination findings

Identify a tense, rapidly expanding, ecchymotic swelling beneath the surgical incision.

This clinical finding is diagnostic of an expanding post-thyroidectomy hematoma.

Assess the physiologic impact of the hematoma

Determine that the hematoma is causing severe extrinsic compression of the trachea and compromising venous drainage, leading to impending airway loss.

Stridor, accessory muscle use, and significant hypoxia indicate that the airway is critically narrowed and total obstruction is imminent.

Determine the immediate intervention

Select bedside decompression (opening the skin clips and deep cervical fascia) as the first and most critical action.

Mechanical decompression immediately relieves the tension on the trachea and allows for venous drainage, often restoring the airway enough to safely transport the patient to the operating room for definitive hemostasis.

Key Concept

In a patient with an expanding post-thyroidectomy hematoma causing airway compromise, immediate bedside decompression (opening the wound and deep cervical fascia) is the definitive first step in management, preceding intubation or transport to the operating room.

Estimated Time:1m 15s

Question 4412Question →

A $74$ -year-old woman is evaluated in the clinic following a recent non-traumatic T12 vertebral compression fracture. A dual-energy x-ray absorptiometry (DEXA) scan reveals a T-score of $-3.2$ at the lumbar spine and $-2.9$ at the femoral neck. Her medical history includes type 2 diabetes mellitus, hypertension, and chronic kidney disease. Five years ago, she developed a provoked deep vein thrombosis following orthopedic surgery. Twelve years ago, she underwent lumpectomy followed by localized external beam radiation therapy for early-stage right breast cancer. Current medications include amlodipine, metformin, and cholecalciferol.

Vital signs are within normal limits. Laboratory studies are as follows:

Test	Result	Reference Range
Serum calcium	$9.2$ mg/dL	$8.4-10.2$ mg/dL
Serum phosphorus	$3.8$ mg/dL	$2.7-4.5$ mg/dL
25-hydroxyvitamin D	$38$ ng/mL	$20-50$ ng/mL
Intact parathyroid hormone	$55$ pg/mL	$15-65$ pg/mL
Estimated glomerular filtration rate	$22$ mL/min/ $1.73\text{m}^2$	$> 90$ mL/min/ $1.73\text{m}^2$

Which of the following is the most appropriate pharmacologic intervention to reduce this patient's risk of future fractures?

Subcutaneous denosumab

Oral alendronate

Intravenous zoledronic acid

Subcutaneous teriparatide

Oral raloxifene

Show answer & explanation

Answer: Subcutaneous denosumab

Answer

Subcutaneous denosumab is the most appropriate and safest pharmacologic intervention for this patient's severe osteoporosis, given her multiple comorbidities.

The correct answer is subcutaneous denosumab. This patient has severe osteoporosis, as evidenced by a fragility fracture and a T-score of

-3.2

, requiring immediate pharmacologic intervention. However, her complex medical history restricts her treatment options. She has chronic kidney disease stage 4 with an eGFR of

22

mL/min/

1.73\text{m}^2

. Bisphosphonates (both oral and intravenous) are renally cleared and are strictly contraindicated in patients with an eGFR

< 35

mL/min/

1.73\text{m}^2

due to the risk of systemic accumulation, excessive suppression of bone turnover, and acute renal toxicity. Her history of external beam radiation therapy is an absolute contraindication to teriparatide due to a dose-dependent increased risk of osteosarcoma. Furthermore, her history of provoked deep vein thrombosis contraindicates the use of raloxifene, a selective estrogen receptor modulator that carries a black-box warning for venous thromboembolism. Denosumab is a monoclonal antibody against RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). It is degraded by the reticuloendothelial system rather than the kidneys, making it the preferred and safest agent for treating osteoporosis in patients with severe renal impairment. It does not increase the risk of osteosarcoma or venous thrombosis. Because denosumab can cause significant hypocalcemia, confirming normal serum calcium and vitamin D levels prior to initiation is essential, which this patient has already met.

Step-by-Step Solution

Evaluate the indication for therapy.

The patient has severe osteoporosis, confirmed by a T-score of

-3.2

and a fragility fracture, requiring prompt pharmacologic treatment.

Establishing the baseline need for therapy is the first step before filtering options based on comorbidities.

Analyze renal function against medication safety profiles.

The patient has chronic kidney disease stage 4 (eGFR

22

mL/min/

1.73\text{m}^2

). This definitively rules out both oral and intravenous bisphosphonates.

Renally cleared bisphosphonates can accumulate and cause adynamic bone disease or direct renal toxicity when eGFR is

< 35

mL/min/

1.73\text{m}^2

Assess the impact of oncologic history.

The history of localized external beam radiation therapy absolutely contraindicates the use of teriparatide.

Teriparatide carries a dose-dependent increased risk of osteosarcoma, particularly in irradiated bone.

Assess the impact of vascular history.

The history of provoked deep vein thrombosis contraindicates the use of raloxifene.

Raloxifene, a selective estrogen receptor modulator, significantly increases the risk of venous thromboembolism.

Select the remaining safe and effective agent.

Denosumab effectively treats osteoporosis and is safe to use. Her normal calcium, phosphorus, and vitamin D levels ensure she is optimized to begin this therapy.

Denosumab is degraded by the reticuloendothelial system, not the kidneys, and avoids the specific contraindications associated with her other comorbidities.

Key Concept

Identifying absolute and relative contraindications for osteoporosis medications (bisphosphonates in severe CKD, teriparatide with prior radiation, SERMs with prior VTE) to select the safest pharmacologic intervention.

Question 4413Question →

A 68-year-old woman is brought to the emergency department by emergency medical services after experiencing two episodes of massive hematemesis at home. She has a history of severe osteoarthritis, for which she takes high-dose ibuprofen daily. On arrival, she is alert, oriented, and very anxious, but able to speak in full sentences. Her temperature is 36.8°C (98.2°F), blood pressure is 75/40 mm Hg, pulse is 132/min and thready, respirations are 20/min, and oxygen saturation is 98% on room air. Physical examination reveals pale conjunctivae, cold and diaphoretic extremities, and a soft, non-tender abdomen. Rectal examination demonstrates black, tarry stool. Which of the following initial stabilization steps are indicated simultaneously? (Select all that apply)

Select all that apply

Establishment of two large-bore peripheral intravenous catheters

Initiation of rapid intravenous crystalloid infusion

Performance of an emergent esophagogastroduodenoscopy

Administration of continuous intravenous norepinephrine

Procurement of an urgent computed tomography of the abdomen

Show answer & explanation

Answer: Establishment of two large-bore peripheral intravenous catheters; Initiation of rapid intravenous crystalloid infusion

Answer

The simultaneous establishment of two large-bore peripheral intravenous catheters and initiation of rapid intravenous crystalloid infusion.

This patient is presenting with severe hemorrhagic (hypovolemic) shock secondary to an acute upper gastrointestinal bleed, evidenced by massive hematemesis, melena, profound hypotension, and marked tachycardia. Following the principles of the primary survey (ABCs), her airway and breathing are currently secure (she is alert, speaking, and oxygenating well). However, her circulation is critically compromised. The immediate priority is rapid volume resuscitation to restore tissue perfusion. This requires the simultaneous placement of two large-bore (e.g., 16-gauge or 18-gauge) peripheral intravenous catheters and the rapid infusion of balanced crystalloid solutions, which should be followed promptly by the administration of appropriately crossmatched blood products.

Step-by-Step Solution

Assess the patient's primary survey (Airway, Breathing, Circulation).

Airway is intact and breathing is adequate, but circulation is severely compromised with signs of profound shock (hypotension, tachycardia, altered perfusion).

To identify immediate life-threatening derangements.

Identify the etiology of the shock state.

The clinical presentation (hematemesis, melena, NSAID use) strongly indicates hemorrhagic (hypovolemic) shock secondary to an acute upper gastrointestinal bleed.

To guide the specific initial resuscitation strategy.

Determine the most urgent interventions to restore circulation.

Immediate vascular access and rapid volume replacement with crystalloids (and subsequently blood products) are required simultaneously.

To rapidly restore intravascular volume, improve tissue perfusion, and prevent irreversible ischemic end-organ damage prior to definitive therapy.

Key Concept

In the initial management of severe hemorrhagic shock, securing reliable vascular access with two large-bore peripheral intravenous lines and initiating rapid volume resuscitation take absolute precedence over definitive diagnostic or therapeutic procedures.

Question 4414Question →

A 78-year-old man is evaluated for discharge planning. He was admitted 4 days ago for uncomplicated cellulitis of the right lower extremity. He was initially treated with intravenous cefazolin and has since transitioned to oral cephalexin. His erythema has significantly improved, he is afebrile, and his vital signs are within normal limits.

The patient has a 4-year history of vascular dementia. He is independently ambulatory without an assistive device and is able to feed himself. However, he is incontinent of urine and requires prompting for grooming. He lives with his 76-year-old wife in a single-story home. During a family meeting, his wife tearfully reports that over the past month, the patient has begun wandering outside the house at night. Two weeks ago, local police found him walking along a busy road at 2:00 AM and brought him home. His wife states she is physically exhausted, unable to stay awake to monitor him, and can no longer guarantee his safety at home.

During hospitalization, the patient has been intermittently agitated at night, attempting to leave the ward, which necessitated a 1:1 safety sitter. He does not have any ongoing intravenous medication requirements or complex wound care needs.

Which of the following is the most appropriate disposition plan for this patient?

Discharge home with daily Home Health nursing and physical therapy visits

Transfer to a skilled nursing facility (SNF) for short-term rehabilitation

Transition to a secure long-term care setting for custodial care

Transfer to an inpatient rehabilitation facility (IRF) for cognitive therapy

Discharge home with a prescription for quetiapine and an outpatient geriatric psychiatry referral

Show answer & explanation

Answer: Transition to a secure long-term care setting for custodial care

Answer

Transition to a secure long-term care setting for custodial care

The patient is medically stable and physically independent, but lacks decision-making capacity regarding his safety and requires 24-hour supervision due to high-risk wandering. Because he does not have a 'skilled' need (e.g., daily PT/OT/ST, IV medications, or complex wound care), he does not qualify for a short-term Skilled Nursing Facility (SNF) under Medicare. Home discharge is unsafe because his wife is overwhelmed and cannot provide the necessary 24/7 supervision. Therefore, long-term custodial care in a secure memory unit is the most appropriate disposition.

Step-by-Step Solution

Evaluate the patient's acute medical and rehabilitation needs.

The patient is on oral antibiotics, is independently ambulatory, and is medically stable, indicating no acute 'skilled' nursing or rehabilitation needs.

To determine if the patient qualifies for Medicare-covered post-acute care such as an SNF or IRF.

Assess the patient's functional and safety status.

The patient has moderate-to-severe dementia with a high-risk wandering behavior, and his wife is unable to provide 24/7 supervision at home.

To determine the required level of supervision and whether a home discharge is safe.

Match the patient's needs to the appropriate care setting.

The patient requires a secure environment for continuous supervision without acute medical interventions, making long-term custodial care the correct setting.

To finalize the disposition plan based on clinical safety and regulatory criteria.

Key Concept

Patients who require 24-hour supervision for safety due to cognitive impairment, but who lack an acute skilled nursing or rehabilitation need, require long-term custodial care rather than a short-term Skilled Nursing Facility (SNF) stay.

Question 4415Question →

Progressive abdominal swelling and bilateral lower extremity edema prompted a 58-year-old man to seek medical evaluation. Over the past two months, he has unintentionally lost 5 kg (11 lb) and reports early satiety. His medical history includes alcohol use disorder and a 30-pack-year smoking history. Vital signs are within normal limits. Abdominal examination demonstrates shifting dullness, and there is 2+ pitting edema in both legs. The physician performs a paracentesis to determine the etiology of the fluid accumulation. Laboratory analysis reveals the following:

Serum studies:
Albumin: 3.2 g/dL
Total protein: 5.8 g/dL

Ascitic fluid analysis:
Appearance: Yellow, clear
Leukocyte count: 180 /mm³ (80% mononuclear cells)
Albumin: 0.9 g/dL
Total protein: 1.4 g/dL
Amylase: 35 U/L

Based on the laboratory findings, which of the following is the most likely cause of this patient's ascites?

Liver cirrhosis

Right-sided heart failure

Peritoneal carcinomatosis

Nephrotic syndrome

Chronic pancreatitis

Show answer & explanation

Answer: Liver cirrhosis

Answer

Liver cirrhosis

The correct diagnosis is liver cirrhosis. The evaluation of new-onset ascites requires interpreting two key laboratory parameters: the serum-ascites albumin gradient (SAAG) and the ascitic fluid total protein. The SAAG is calculated by subtracting the ascitic fluid albumin from the serum albumin (

3.2 - 0.9 = 2.3 \text{ g/dL}

). A SAAG

\geq 1.1 \text{ g/dL}

indicates that the ascites is caused by portal hypertension. Once portal hypertension is established, the ascitic fluid total protein is used to differentiate hepatic from post-hepatic causes. An ascitic total protein

< 2.5 \text{ g/dL}

indicates liver cirrhosis (or late Budd-Chiari syndrome) because fibrotic changes in the liver prevent the free passage of protein into the peritoneal space. Conversely, a value

\geq 2.5 \text{ g/dL}

would suggest post-hepatic causes like right-sided heart failure.

Step-by-Step Solution

Calculate the serum-ascites albumin gradient (SAAG).

SAAG = 3.2 \text{ g/dL} - 0.9 \text{ g/dL} = 2.3 \text{ g/dL}

The SAAG determines whether the ascites is driven by portal hypertension or other mechanisms.

Interpret the calculated SAAG value.

The value of

2.3 \text{ g/dL}

\geq 1.1 \text{ g/dL}

A SAAG

\geq 1.1 \text{ g/dL}

confirms the presence of portal hypertension.

Evaluate the ascitic fluid total protein to narrow the differential diagnosis of portal hypertension.

The ascitic fluid total protein is

1.4 \text{ g/dL}

, which is

< 2.5 \text{ g/dL}

In the setting of portal hypertension, a low ascitic total protein (

< 2.5 \text{ g/dL}

) points to sinusoidal or pre-sinusoidal causes (e.g., liver cirrhosis) because hepatic fibrosis restricts protein leakage. Post-sinusoidal causes (e.g., right heart failure) have high total protein.

Key Concept

Interpretation of the Serum-Ascites Albumin Gradient (SAAG) and ascitic fluid total protein to determine the etiology of ascites.

Estimated Time:1m 30s

Question 4416Question →

Match each patient's clinical presentation and associated laboratory profile with the most appropriate diagnostic category of acute kidney injury.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matching pairs are: 1) Vomiting and bland sediment matches with Prerenal azotemia; 2) Gentamicin and muddy brown casts matches with Acute tubular necrosis; 3) Omeprazole, rash, and WBC casts matches with Acute interstitial nephritis; 4) Post-URI hematuria and RBC casts matches with Acute glomerulonephritis.

Prerenal azotemia is driven by hypovolemia, resulting in a high BUN:creatinine ratio and a concentrated, bland urine sediment. Acute tubular necrosis (ATN) is frequently caused by nephrotoxins like aminoglycosides, leading to epithelial cell death and pathognomonic muddy brown granular casts. Acute interstitial nephritis (AIN) is a drug-induced allergic reaction (e.g., PPIs) marked by WBCs and WBC casts alongside systemic signs like rash. Acute glomerulonephritis involves glomerular capillary inflammation, allowing RBCs to leak into the tubules and form dysmorphic RBCs and RBC casts.

Step-by-Step Solution

Analyze the clinical history and BUN/creatinine ratio for evidence of hypoperfusion.

Patient 1 has a clear history of fluid loss (vomiting) and a BUN:Cr ratio > 20:1, indicating intact tubular function trying to conserve volume.

BUN is reabsorbed alongside sodium and water in the proximal tubule; in low-flow states, disproportionate BUN elevation occurs, pointing to a prerenal cause.

Evaluate the urinalysis sediment findings for specific cast elements.

Muddy brown casts are found in Patient 2, WBC casts in Patient 3, and RBC casts in Patient 4.

Urine sediment acts as a 'liquid biopsy'. Casts form within the renal tubules and directly reflect the underlying pathology (tubular cell death, interstitial inflammation, or glomerular bleeding).

Match the combined clinical and laboratory profile to the correct pathophysiologic category of acute kidney injury.

The distinct laboratory profiles successfully map to Prerenal azotemia, Acute tubular necrosis, Acute interstitial nephritis, and Acute glomerulonephritis.

Establishing the precise etiology of AKI through laboratory interpretation is critical for guiding specific management (e.g., volume repletion, stopping offending drugs, or specific immunosuppression).

Key Concept

Interpretation of urinary sediment and BUN-to-creatinine ratio is essential for differentiating the primary mechanisms of acute kidney injury: prerenal, intrinsic tubular, interstitial, and glomerular disease.

Estimated Time:1m 0s

Question 4417Question →

Match each ambulatory patient's clinical risk profile with the most appropriate next step in preventive care and screening based on current guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings align each high-risk patient profile with their guideline-indicated specific screening modality and interval.

Each patient presents with a specific risk-enhancing factor that modifies average-risk screening guidelines. The 38-year-old woman requires both MRI and mammography due to prior chest radiation. The 45-year-old man needs a 5-year interval colonoscopy due to his father's early diagnosis. The 52-year-old woman meets the updated LDCT criteria (age 50 or older, 20 or more pack-years, quit less than 15 years ago). The 60-year-old woman needs a DEXA scan before age 65 due to her high-risk medication and comorbidity profile.

Step-by-Step Solution

Evaluate the 38-year-old woman with prior mantle field radiation.

Identify high-risk status for breast cancer.

Chest radiation before age 30 necessitates intensive breast screening with mammography and MRI.

Assess the 45-year-old man with a family history of early-onset colon cancer.

Determine the need for colonoscopy every 5 years.

A first-degree relative diagnosed before age 60 requires colonoscopy starting at 40 (or 10 years prior) and repeating every 5 years.

Analyze the 52-year-old former smoker's history.

Determine eligibility for lung cancer screening.

Age 50 to 80, 20 or more pack-year history, and quit within 15 years meets USPSTF criteria for annual LDCT.

Review the 60-year-old woman with rheumatoid arthritis on corticosteroids.

Identify the need for early osteoporosis screening.

Postmenopausal women under 65 with significant clinical risk factors require DEXA screening.

Key Concept

Application of modified preventive screening guidelines for high-risk patient populations.

Question 4418Question →

A 34-year-old woman is evaluated during a preoperative assessment prior to an elective laparoscopic cholecystectomy. She has a history of systemic lupus erythematosus, which is currently well-controlled on hydroxychloroquine. She reports no history of heavy menses, excessive bruising, or abnormal bleeding following a dental extraction 5 years ago. Vital signs are within normal limits. Physical examination is unremarkable.

Laboratory results are as follows:

Laboratory Test	Result	Reference Range
Hemoglobin	12.8 g/dL	12.0-16.0 g/dL
Platelet count	210,000/mm³	150,000-400,000/mm³
Prothrombin time (PT)	12 seconds	11-15 seconds
Activated partial thromboplastin time (aPTT)	58 seconds	25-40 seconds

Due to the isolated prolonged aPTT, a mixing study is performed using equal parts of the patient's plasma and normal pooled plasma. The repeat aPTT on the mixture is 54 seconds.

Which of the following is the most likely underlying cause of this patient's laboratory findings?

Presence of an inhibitor directed against phospholipid-binding proteins

Deficiency of coagulation factor VIII

Defective platelet adhesion and reduced carrier protein for factor VIII

Impaired gamma-carboxylation of coagulation factors

Systemic consumption of coagulation factors and platelets

Show answer & explanation

Answer: Presence of an inhibitor directed against phospholipid-binding proteins

Answer

Presence of an inhibitor directed against phospholipid-binding proteins

The correct answer accurately describes the pathophysiology of a lupus anticoagulant (an antiphospholipid antibody). In a mixing study, the patient's plasma is mixed 1:1 with normal pooled plasma. If the patient has a factor deficiency (e.g., Hemophilia A, von Willebrand disease), the normal plasma will replace the missing factors, and the aPTT will correct to a normal range. If the patient has an inhibitor (e.g., lupus anticoagulant), the inhibitor will bind to the phospholipids in the normal plasma reagent as well, and the aPTT will remain prolonged (fail to correct). Given this patient's history of SLE and the failure of the aPTT to correct, a lupus anticoagulant is the most likely cause.

Step-by-Step Solution

Interpret the baseline coagulation panel.

The patient has an isolated prolonged aPTT with a normal PT and normal platelet count.

An isolated prolonged aPTT indicates a defect in the intrinsic or common coagulation pathway.

Analyze the results of the mixing study.

The aPTT remains prolonged (54 seconds) after adding normal pooled plasma.

Failure to correct on a mixing study differentiates a coagulation inhibitor (which neutralizes factors in the normal plasma) from a factor deficiency (which is replenished by the normal plasma).

Correlate the laboratory findings with the patient's clinical history.

The patient has SLE, no bleeding history, and an inhibitor pattern on the mixing study, pointing to a lupus anticoagulant.

Lupus anticoagulants are antiphospholipid antibodies that bind to phospholipids in the assay, artifactually prolonging the aPTT in vitro despite promoting a prothrombotic state in vivo.

Key Concept

Interpretation of Coagulation Mixing Studies

Estimated Time:1m 0s

Question 4419Question →

A 31-year-old woman, gravida 2, para 1, presents for her initial prenatal visit at 10 weeks gestation. Her first pregnancy four years ago was uncomplicated, and her prenatal laboratory panel at that time was negative for human immunodeficiency virus (HIV), syphilis, hepatitis B, and hepatitis C. She has been in a monogamous relationship with her husband for six years. Neither has a history of injection drug use, sexually transmitted infections, or occupational blood exposures. Her body mass index is $22 \text{ kg/m}^2$ . She feels well and takes a daily prenatal vitamin. Vital signs are within normal limits. In addition to a complete blood count, blood typing with rhesus factor, and screening for HIV, syphilis, and hepatitis B, which of the following screening tests is most appropriate to order for this patient today?

Hepatitis C virus antibody testing

Chlamydia trachomatis nucleic acid amplification testing

Type 2 herpes simplex virus serology

Hemoglobin A1c measurement

Toxoplasma gondii immunoglobulin G and M testing

Show answer & explanation

Answer: Hepatitis C virus antibody testing

Answer

Hepatitis C virus antibody testing

The correct answer is Hepatitis C virus antibody testing. According to updated guidelines from the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG), universal screening for hepatitis C virus (HCV) is recommended for all pregnant individuals during each pregnancy. This recommendation aims to identify chronic infections, facilitate postpartum treatment, and monitor infants for vertical transmission. It replaces previous guidelines that advised either risk-based screening or a single lifetime screening.

Step-by-Step Solution

Analyze the patient's demographic and obstetric profile.

The patient is a 31-year-old female at 10 weeks gestation with no significant high-risk behaviors or comorbidities.

Establishing baseline risk factors is required to differentiate between universal and risk-based prenatal screening guidelines.

Evaluate the indication for Hepatitis C virus (HCV) screening.

HCV screening is indicated today despite her previous negative screen four years ago.

The CDC and ACOG updated guidelines to recommend universal HCV screening during every pregnancy, superseding the older once-in-a-lifetime recommendation.

Exclude other screening tests based on patient-specific data.

Tests for Chlamydia, early diabetes, HSV, and Toxoplasma are ruled out.

Her age (>25) and monogamy exclude routine Chlamydia screening; her normal BMI excludes early HbA1c testing; and HSV/Toxoplasma are not universally screened.

Key Concept

Universal hepatitis C screening is recommended during each pregnancy, regardless of prior negative test results or the absence of new risk factors.

Estimated Time:1m 15s

Question 4420Question →

A 65-year-old man presents to the primary care clinic for an annual health maintenance examination. His past medical history is significant for type 2 diabetes mellitus, hypertension, and obesity. He is a former smoker, having smoked 1 pack per day for 40 years before quitting 2 years ago. He feels well and reports no acute symptoms. His vital signs and physical examination are unremarkable.

Review of his preventive health record reveals the following:
- A screening colonoscopy 6 years ago was completely normal, with no polyps identified.
- He received a Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine 12 years ago.
- He received two doses of the recombinant zoster vaccine at age 50.
- He received the seasonal influenza vaccine one month ago.
- He has never undergone abdominal imaging, chest imaging, or bone density screening.
- He has not received any pneumococcal vaccines.

Based on current guidelines, which of the following interventions are indicated for this patient at today's visit? (Select all that apply)

Select all that apply

One-time screening for abdominal aortic aneurysm with ultrasonography

Annual screening for lung cancer with low-dose computed tomography

Administration of a tetanus and diphtheria toxoids (Td) or Tdap booster vaccine

Screening for colorectal cancer with colonoscopy

Screening for osteoporosis with dual-energy x-ray absorptiometry (DXA)

Administration of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) alone

Show answer & explanation

Answer: One-time screening for abdominal aortic aneurysm with ultrasonography; Annual screening for lung cancer with low-dose computed tomography; Administration of a tetanus and diphtheria toxoids (Td) or Tdap booster vaccine

Answer

The indicated interventions are one-time screening for abdominal aortic aneurysm with ultrasonography, annual screening for lung cancer with low-dose computed tomography, and administration of a tetanus and diphtheria (Td) or Tdap booster vaccine.

The indicated interventions are based on age, sex, and smoking history. The patient requires a one-time abdominal ultrasound to screen for an abdominal aortic aneurysm because he is a man aged 65-75 with a smoking history. He requires annual low-dose computed tomography (LDCT) for lung cancer screening because he is between 50-80 years old, has at least a 20 pack-year smoking history, and quit within the last 15 years. Finally, he requires a Td or Tdap booster because it has been over 10 years since his last dose.

Step-by-Step Solution

Evaluate the patient's age and smoking history for cancer and vascular screening guidelines.

The patient is a 65-year-old man with a 40 pack-year smoking history who quit 2 years ago.

Age and smoking history are primary determinants for AAA and lung cancer screening.

Apply AAA screening guidelines.

He meets criteria for a one-time AAA screening with abdominal ultrasonography.

The USPSTF recommends a one-time AAA screening for men aged 65 to 75 who have ever smoked (100 or more cigarettes in a lifetime).

Apply lung cancer screening guidelines.

He meets criteria for annual lung cancer screening with low-dose CT.

The USPSTF recommends annual LDCT for adults aged 50 to 80 with a 20 or more pack-year smoking history who currently smoke or quit within the last 15 years.

Review the immunization record.

His last Tdap was 12 years ago, which is past the 10-year booster interval. He needs a Td or Tdap booster.

Adults require a tetanus toxoid-containing booster every 10 years to maintain immunity against tetanus and diphtheria.

Evaluate the remaining options for appropriateness based on his history.

Colonoscopy is not due (normal 6 years ago, 10-year interval). DXA is not routinely indicated for men. PPSV23 alone is incorrect for initial pneumococcal vaccination.

Preventing unnecessary testing and adhering to current vaccine sequencing guidelines is critical for appropriate patient management.

Key Concept

Application of age- and risk-factor specific preventive screening and immunization guidelines for older adults.

PreviousPage 221 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept